Insider-Transaktionen

EDGAR

CURTISS-WRIGHT CORPORATION

Von Direktoren, Führungskräften und 10-%-Eignern auf den SEC-Formularen 3, 4 und 5 gemeldete Transaktionen, aus dem XML jeder Einreichung gelesen. Codes und ihr Wortlaut stammen von der SEC.

Das Formular 4 ist innerhalb von zwei Geschäftstagen nach der Transaktion einzureichen; die jüngsten Geschäfte sind daher möglicherweise noch nicht gemeldet.

Zeitfenster: Transaktionen ab dem 18. Nov. 2025.

Käufe am offenen Markt (Code P)
1 Transaktionen, 209,3801 Aktien
Summe Aktien × Preis je Aktie: 148.999,066762
Verkäufe am offenen Markt (Code S)
28 Transaktionen, 34.729 Aktien
Summe Aktien × Preis je Aktie: 22.969.433,83

Die Summen addieren die aufgeführten eingereichten Transaktionen; sie zählen das Gemeldete und messen keine Richtung.

1–50 von 78 angezeigt

Insider-Transaktionen, neueste zuerst, wie auf den SEC-Formularen 3, 4 und 5 eingereicht
DatumMeldende PersonCodeErworben oder veräußertAktienPreis je Aktie, wie eingereichtWert (abgeleitet)Aktien danach im BesitzDirekt oder indirektKästchen zu Rule 10b5-1AnmerkungenQuelle
28. Aug. 2026 Eingereicht am 31. Aug. 2026Wyche Larry D Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)100596,74
59.674

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 59674.00.

1.414Direkt (D) Nein
F1
  • F1 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.
Einreichung öffnen 0001628280-26-059568 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
27. Aug. 2026 Eingereicht am 27. Aug. 2026Watts John C Officer: EVP Chief Growth Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)1.035619,46
641.141,1

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 641141.10.

2.736Direkt (D) Nein
F1
  • F1 The reporting person contributed Issuer common stock (Common Stock) to an exchange fund in exchange for shares of the exchange fund. For purposes of determining the number of shares of the exchange fund issuable pursuant to such exchange, the Common Stock was valued at $619.46 per share, which was the closing price of the Common Stock on the New York Stock Exchange on August 26, 2026. The transaction with the exchange fund closed on August 27, 2025.
Einreichung öffnen 0001628280-26-059267 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
10. Aug. 2026 Eingereicht am 10. Aug. 2026Lyash Jeffrey J. Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Erworben (A)209,3801711,62
148.999,066762

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 148999.066762.

257,3801Direkt (D) Nein— Einreichung öffnen 0001628280-26-055200 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
6. Juli 2026 Eingereicht am 6. Juli 2026Watts John C Officer: EVP Chief Growth Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)9634,88
5.713,92

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 5713.92.

3.771Direkt (D) Nein
F1, F2
  • F1 Shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP), under which the Reporting Person agrees to payroll deductions prior to the commencement of a six-month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • F2 In accordance with the terms of the ESPP, the purchase price is calculated by giving a 15% discount on the average selling price of the Issuer's common stock price on June 30, 2026, the last day of the offering period.
Einreichung öffnen 0001628280-26-047237 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
6. Juli 2026 Eingereicht am 6. Juli 2026Bamford Lynn M Director · Officer: Chair and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)17634,88
10.792,96

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 10792.96.

45.651Direkt (D) Nein
F1, F2
  • F1 Shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP), under which the Reporting Person agrees to payroll deductions prior to the commencement of a six-month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • F2 In accordance with the terms of the ESPP, the purchase price is calculated by giving a 15% discount on the average selling price of the Issuer's common stock price on June 30, 2026, the last day of the offering period.
Einreichung öffnen 0001628280-26-047231 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
6. Juli 2026 Eingereicht am 6. Juli 2026Rayment Kevin Officer: Executive VP and COO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)26634,88
16.506,88

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 16506.88.

31.519Direkt (D) Nein
F1, F2
  • F1 Shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP), under which the Reporting Person agrees to payroll deductions prior to the commencement of a six-month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • F2 In accordance with the terms of the ESPP, the purchase price is calculated by giving a 15% discount on the average selling price of the Issuer's common stock price on June 30, 2026, the last day of the offering period.
Einreichung öffnen 0001628280-26-047236 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
6. Juli 2026 Eingereicht am 6. Juli 2026McDonald George P. Officer: Executive VP and Corporate Sec
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)25634,88
15.872

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 15872.00.

4.235Direkt (D) Nein
F1, F2
  • F1 Shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP), under which the Reporting Person agrees to payroll deductions prior to the commencement of a six-month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • F2 In accordance with the terms of the ESPP, the purchase price is calculated by giving a 15% discount on the average selling price of the Issuer's common stock price on June 30, 2026, the last day of the offering period.
Einreichung öffnen 0001628280-26-047242 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
6. Juli 2026 Eingereicht am 6. Juli 2026Farkas K Christopher Officer: Executive VP and CFO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)21634,88
13.332,48

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 13332.48.

4.274Direkt (D) Nein
F1, F2
  • F1 Shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP), under which the Reporting Person agrees to payroll deductions prior to the commencement of a six-month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • F2 In accordance with the terms of the ESPP, the purchase price is calculated by giving a 15% discount on the average selling price of the Issuer's common stock price on June 30, 2026, the last day of the offering period.
Einreichung öffnen 0001628280-26-047233 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
15. Juni 2026 Eingereicht am 15. Juni 2026Watts John C Officer: EVP Chief Growth Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)200770,56
154.112

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 154112.00.

3.762Direkt (D) Ja
F1, F2
  • F1 Sale was made in accordance with a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2026 and maintained by the Reporting Person's financial advisor.
  • F2 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.
Einreichung öffnen 0001628280-26-043157 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
12. Juni 2026 Eingereicht am 15. Juni 2026Bamford Lynn M Director · Officer: Chair and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)2.500758,20
1.895.500

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 1895500.00.

45.634Direkt (D) Ja
F1, F2, F3
  • F1 Sale was made in accordance with a 10b5-1 plan adopted by the Reporting Person on March 10, 2026 and maintained by the Reporting Person's financial advisor.
  • F2 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.
  • F3 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $754.05 to $766.75, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Einreichung öffnen 0001628280-26-043153 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
9. Juni 2026 Eingereicht am 10. Juni 2026Ogilby Gary A Officer: Senior VP Corp Controller
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)399721,95
288.058,05

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 288058.05.

2.172Direkt (D) Ja
F1, F2, F3
  • F1 Sale was made in accordance with a 10b5-1 plan adopted by the Reporting Person on March 10, 2026 and maintained by the Reporting Person's financial advisor.
  • F2 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.
  • F3 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $705.34 to $736.99, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Einreichung öffnen 0001628280-26-042196 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
9. Juni 2026 Eingereicht am 10. Juni 2026Bamford Lynn M Director · Officer: Chair and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)2.500721,72
1.804.300

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 1804300.00.

48.134Direkt (D) Ja
F1, F2, F3
  • F1 Sale was made in accordance with a 10b5-1 plan adopted by the Reporting Person on March 10, 2026 and maintained by the Reporting Person's financial advisor
  • F2 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.
  • F3 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $703.54 to $739.63, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Einreichung öffnen 0001628280-26-042193 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
1. Juni 2026 Eingereicht am 2. Juni 2026Wallace Peter C Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)221719,99
159.117,79

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 159117.79.

6.209Direkt (D) Nein
F1, F2, F3
  • F1 Shares were acquired through the Corporation's 2024 Omnibus Incentive Plan whereby non-employee directors may elect to defer their compensation, including their annual restricted stock award, and/or receive their annual retainer and meeting fees in the form of stock at a later date.
  • F2 Reflects the annual restricted stock award that was earned in 2021, but receipt was deferred to June 1, 2025. Number of shares acquired is calculated based on the value of the award ($125,000) divided by the closing price of $115.24 for the Issuer's common stock as reported by the New York Stock Exchange on February 16, 2021, the date the Board initially approved the award. The number of shares is rounded up to the nearest whole share and includes dividend credits earned on outstanding award. This amount reflects 20% of the Reporting Person's restricted stock award as the reporting person elected to receive the restricted stock in five equal installments beginning June 1, 2025.
  • F3 Price is based on the closing market price for the Issuer's securities on the New York Stock Exchange as of June 1, 2026. The date recipient elected to receive his shares.
Einreichung öffnen 0001628280-26-039795 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
29. Mai 2026 Eingereicht am 2. Juni 2026MINOR GLENDA J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)20747,61
14.952,2

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 14952.20.

2.491,01Direkt (D) Nein
F1, F2, F3
  • F1 Shares were acquired through the Corporation's 2024 Omnibus Incentive Plan whereby non-employee directors may elect to receive their annual retainer, committee chair, and meeting fees in the form of stock.
  • F2 Number of shares is calculated by taking the amount of the Reporting Person's earned retainer and dividing that amount by the closing price of the Issuer's common stock on the date such retainer was earned.
  • F3 Price is based on the closing market price for the Issuer's securities on the New York Stock Exchange as of May 29, 2026. The date recipient elected to receive her shares.
Einreichung öffnen 0001628280-26-039799 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
27. Mai 2026 Eingereicht am 27. Mai 2026Watts John C Officer: EVP Chief Growth Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)220752,91
165.640,2

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 165640.20.

3.962Direkt (D) Ja
F1, F2
  • F1 Sale was made in accordance with a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2026 and maintained by the Reporting Person's financial advisor.
  • F2 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.
Einreichung öffnen 0001628280-26-038454 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
12. Mai 2026 Eingereicht am 14. Mai 2026MINOR GLENDA J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)221735,34
162.510,14

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 162510.14.

2.471,01Direkt (D) Nein
F1, F2, F3
  • F1 Shares were acquired through the Corporation's 2024 Omnibus Incentive Plan whereby non-employee directors may elect to defer receipt of their annual restricted stock award to a later date.
  • F2 Number of shares acquired is calculated based on the value of the award ($125,000) divided by the closing price of $115.24 for the Issuer's common stock as reported by the New York Stock Exchange on February 16, 2021, the date the Board initially approved the award. The number of shares is rounded up to the nearest whole share and includes dividend credits earned on outstanding award. This amount reflects 20% of the reporting person's restricted stock award as the reporting person elected to receive the restricted stock award in five equal annual installments beginning May 12, 2024.
  • F3 Price is based on the closing market price for the Issuer's securities on the New York Stock Exchange as of May 12, 2026. The date reporting person elected to receive her shares.
Einreichung öffnen 0001628280-26-035111 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
7. Mai 2026 Eingereicht am 11. Mai 2026Lyash Jeffrey J. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)480—48Direkt (D) Nein
F1, F2
  • F1 Shares were issued pursuant to the Company's 2024 Omnibus Incentive Plan in which newly elected non-employee directors receive an initial grant of restricted stock in the amount of $35,000 for service on the board. The restrictions on these shares lapse upon the shorter of (a) five years from the date of grant or (b) until such time as the service of the recipient as a non-employee director of the Company shall have ended by reason of his or her (i) death or disability or (ii) failure to be reelected.
  • F2 The number of shares calculated is based on the value of the award ($35,000.00) divided by the closing price of $724.43 for Issuer's common stock as reported by the New York Stock Exchange on May 7, 2026, the date the reporting person was elected to the Board of Directors.
Einreichung öffnen 0001628280-26-033163 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
18. März 2026 Eingereicht am 19. März 2026Farkas K Christopher Officer: Executive VP and CFO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)1.265689,69
872.457,85

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 872457.85.

4.253Direkt (D) Ja
F1, F2
  • F1 Sale was made in accordance with a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2025 and maintained by the Reporting Person's financial advisor.
  • F2 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $681.18 to $699.31, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Einreichung öffnen 0001628280-26-019786 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
18. März 2026 Eingereicht am 19. März 2026Ogilby Gary A Officer: Senior VP Corp Controller
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)252689,14
173.663,28

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 173663.28.

2.571Direkt (D) Ja
F1, F2
  • F1 Sale was made in accordance with a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2025 and maintained by the Reporting Person's financial advisor.
  • F2 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $682.74 to $698.09, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Einreichung öffnen 0001628280-26-019788 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
17. März 2026 Eingereicht am 18. März 2026Watts John C Officer: EVP Chief Growth Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)220678,11
149.184,2

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 149184.20.

4.182Direkt (D) Nein
F3, F4
  • F3 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.
  • F4 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $671.53 to $681.02, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Einreichung öffnen 0001628280-26-019408 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
17. März 2026 Eingereicht am 18. März 2026Rayment Kevin Officer: Executive VP and COO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)907677,38
614.383,66

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 614383.66.

31.493Direkt (D) Nein
F3, F4
  • F3 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.
  • F4 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $671.52 to $681, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Einreichung öffnen 0001628280-26-019397 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
17. März 2026 Eingereicht am 18. März 2026Farkas K Christopher Officer: Executive VP and CFO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)918677,46
621.908,28

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 621908.28.

5.518Direkt (D) Nein
F3, F4
  • F3 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.
  • F4 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $669.72 to $681.43, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Einreichung öffnen 0001628280-26-019395 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
17. März 2026 Eingereicht am 18. März 2026McDonald George P. Officer: Executive VP and Corporate Sec
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)151678,07
102.388,57

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 102388.57.

4.210Direkt (D) Nein
F3, F4
  • F3 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.
  • F4 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $671.25 to $681.02, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Einreichung öffnen 0001628280-26-019400 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
17. März 2026 Eingereicht am 18. März 2026Ogilby Gary A Officer: Senior VP Corp Controller
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)148678,30
100.388,4

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 100388.40.

2.823Direkt (D) Nein
F3, F4
  • F3 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.
  • F4 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $671.53 to $681.02, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Einreichung öffnen 0001628280-26-019402 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
17. März 2026 Eingereicht am 18. März 2026Bamford Lynn M Director · Officer: Chair and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)3.225676,70
2.182.357,5

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 2182357.50.

50.634Direkt (D) Nein
F3, F4
  • F3 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.
  • F4 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $669.05 to $681, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Einreichung öffnen 0001628280-26-019388 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
17. März 2026 Eingereicht am 18. März 2026Freda Robert F Officer: Senior VP Treasurer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)140678,61
95.005,4

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 95005.40.

5.343Direkt (D) Nein
F3, F4
  • F3 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.
  • F4 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $671.23 to $681.66, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Einreichung öffnen 0001628280-26-019405 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. März 2026 Eingereicht am 18. März 2026Watts John C Officer: EVP Chief Growth Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Erworben (A)5120—4.402Direkt (D) Nein
F1, F2
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
Einreichung öffnen 0001628280-26-019408 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. März 2026 Eingereicht am 18. März 2026Watts John C Officer: EVP Chief Growth Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivatives Wertpapier: Restricted Stock Unit — Basiswert Common Stock (512) — Ausübungspreis 0
Veräußert (D)5120—895Direkt (D) Nein
F2, F1, F5
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F5 Share total includes dividend credits earned on prior outstanding grants.
Einreichung öffnen 0001628280-26-019408 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. März 2026 Eingereicht am 18. März 2026Rayment Kevin Officer: Executive VP and COO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Erworben (A)2.5040—32.400Direkt (D) Nein
F1, F2
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
Einreichung öffnen 0001628280-26-019397 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. März 2026 Eingereicht am 18. März 2026Rayment Kevin Officer: Executive VP and COO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivatives Wertpapier: Restricted Stock Unit — Basiswert Common Stock (2.504) — Ausübungspreis 0
Veräußert (D)2.5040—3.928Direkt (D) Nein
F2, F1, F5
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F5 Share total includes dividend credits earned on prior outstanding grants.
Einreichung öffnen 0001628280-26-019397 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. März 2026 Eingereicht am 18. März 2026Farkas K Christopher Officer: Executive VP and CFO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Erworben (A)2.1830—6.436Direkt (D) Nein
F1, F2
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
Einreichung öffnen 0001628280-26-019395 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. März 2026 Eingereicht am 18. März 2026Farkas K Christopher Officer: Executive VP and CFO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivatives Wertpapier: Restricted Stock Unit — Basiswert Common Stock (2.183) — Ausübungspreis 0
Veräußert (D)2.1830—9.366Direkt (D) Nein
F2, F1, F5
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F5 Share total includes dividend credits earned on prior outstanding grants.
Einreichung öffnen 0001628280-26-019395 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. März 2026 Eingereicht am 18. März 2026McDonald George P. Officer: Executive VP and Corporate Sec
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Erworben (A)3500—4.361Direkt (D) Nein
F1, F2
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
Einreichung öffnen 0001628280-26-019400 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. März 2026 Eingereicht am 18. März 2026McDonald George P. Officer: Executive VP and Corporate Sec
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivatives Wertpapier: Restricted Stock Unit — Basiswert Common Stock (350) — Ausübungspreis 0
Veräußert (D)3500—1.112Direkt (D) Nein
F2, F1, F5
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F5 Share total includes dividend credits earned on prior outstanding grants.
Einreichung öffnen 0001628280-26-019400 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. März 2026 Eingereicht am 18. März 2026Ogilby Gary A Officer: Senior VP Corp Controller
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Erworben (A)4000—2.971Direkt (D) Nein
F1, F2
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
Einreichung öffnen 0001628280-26-019402 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. März 2026 Eingereicht am 18. März 2026Ogilby Gary A Officer: Senior VP Corp Controller
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivatives Wertpapier: Restricted Stock Unit — Basiswert Common Stock (400) — Ausübungspreis 0
Veräußert (D)4000—4.420Direkt (D) Nein
F2, F1, F5
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F5 Share total includes dividend credits earned on prior outstanding grants.
Einreichung öffnen 0001628280-26-019402 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. März 2026 Eingereicht am 18. März 2026Bamford Lynn M Director · Officer: Chair and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Erworben (A)7.6670—53.859Direkt (D) Nein
F1, F2
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
Einreichung öffnen 0001628280-26-019388 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. März 2026 Eingereicht am 18. März 2026Bamford Lynn M Director · Officer: Chair and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivatives Wertpapier: Restricted Stock Unit — Basiswert Common Stock (7.667) — Ausübungspreis 0
Veräußert (D)7.6670—14.614Direkt (D) Nein
F2, F1, F5
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F5 Share total includes dividend credits earned on prior outstanding grants.
Einreichung öffnen 0001628280-26-019388 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. März 2026 Eingereicht am 18. März 2026Freda Robert F Officer: Senior VP Treasurer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Erworben (A)2960—5.483Direkt (D) Nein
F1, F2
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
Einreichung öffnen 0001628280-26-019405 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
16. März 2026 Eingereicht am 18. März 2026Freda Robert F Officer: Senior VP Treasurer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivatives Wertpapier: Restricted Stock Unit — Basiswert Common Stock (296) — Ausübungspreis 0
Veräußert (D)2960—4.269Direkt (D) Nein
F2, F1, F5
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F5 Share total includes dividend credits earned on prior outstanding grants.
Einreichung öffnen 0001628280-26-019405 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
9. März 2026 Eingereicht am 10. März 2026McDonald George P. Officer: Executive VP and Corporate Sec
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivatives Wertpapier: Restricted Stock Unit — Basiswert Common Stock (304) — Ausübungspreis 0
Erworben (A)3040—1.462Direkt (D) Nein
F2, F3, F4
  • F2 This is a time-based restricted stock unit (RSU) grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.
  • F3 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F4 Share total includes dividend credits earned on prior outstanding grants.
Einreichung öffnen 0001628280-26-016434 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
9. März 2026 Eingereicht am 10. März 2026Rayment Kevin Officer: Executive VP and COO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivatives Wertpapier: Restricted Stock Unit — Basiswert Common Stock (652) — Ausübungspreis 0
Erworben (A)6520—6.432Direkt (D) Nein
F1, F2, F3
  • F1 This is a time-based restricted stock unit (RSU) grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F3 Share total includes dividend credits earned on prior outstanding grants.
Einreichung öffnen 0001628280-26-016432 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
9. März 2026 Eingereicht am 10. März 2026Farkas K Christopher Officer: Executive VP and CFO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivatives Wertpapier: Restricted Stock Unit — Basiswert Common Stock (645) — Ausübungspreis 0
Erworben (A)6450—11.549Direkt (D) Nein
F1, F2, F3
  • F1 This is a time-based restricted stock unit (RSU) grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F3 Share total includes dividend credits earned on prior outstanding grants.
Einreichung öffnen 0001628280-26-016430 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
9. März 2026 Eingereicht am 10. März 2026Bamford Lynn M Director · Officer: Chair and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivatives Wertpapier: Restricted Stock Unit — Basiswert Common Stock (2.735) — Ausübungspreis 0
Erworben (A)2.7350—22.281Direkt (D) Nein
F1, F2, F3
  • F1 This is a time-based restricted stock unit (RSU) grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F3 Share total includes dividend credits earned on prior outstanding grants.
Einreichung öffnen 0001628280-26-016427 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
9. März 2026 Eingereicht am 10. März 2026Watts John C Officer: EVP Chief Growth Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivatives Wertpapier: Restricted Stock Unit — Basiswert Common Stock (183) — Ausübungspreis 0
Erworben (A)1830—1.407Direkt (D) Nein
F1, F2, F3
  • F1 This is a time-based restricted stock unit (RSU) grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F3 Share total includes dividend credits earned on prior outstanding grants.
Einreichung öffnen 0001628280-26-016444 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
9. März 2026 Eingereicht am 10. März 2026Ogilby Gary A Officer: Senior VP Corp Controller
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivatives Wertpapier: Restricted Stock Unit — Basiswert Common Stock (108) — Ausübungspreis 0
Erworben (A)1080—4.820Direkt (D) Nein
F1, F2, F3
  • F1 This is a time-based restricted stock unit (RSU) grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F3 Share total includes dividend credits earned on prior outstanding grants.
Einreichung öffnen 0001628280-26-016438 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
9. März 2026 Eingereicht am 10. März 2026Freda Robert F Officer: Senior VP Treasurer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivatives Wertpapier: Restricted Stock Unit — Basiswert Common Stock (82) — Ausübungspreis 0
Erworben (A)820—4.565Direkt (D) Nein
F1, F2, F3
  • F1 This is a time-based restricted stock unit (RSU) grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F3 Share total includes dividend credits earned on prior outstanding grants.
Einreichung öffnen 0001628280-26-016440 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
18. Feb. 2026 Eingereicht am 18. Feb. 2026Farkas K Christopher Officer: Executive VP and CFO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)3.105694,51
2.156.453,55

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 2156453.55.

4.253Direkt (D) Ja
F1, F2, F3
  • F1 Sale was made in accordance with a 10b5-1 plan adopted by the Reporting Person on November 10, 2025 and maintained by the Reporting Person's financial advisor.
  • F2 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.
  • F3 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $687.55 to $703.23, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Einreichung öffnen 0001628280-26-009091 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
5. Feb. 2026 Eingereicht am 5. Feb. 2026Ogilby Gary A Officer: Senior VP Corp Controller
S

Open market or private sale of non-derivative or derivative security

Common Stock
Veräußert (D)625624,32
390.200

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 390200.00.

2.571Direkt (D) Ja
F5, F6
  • F5 Sale was made in accordance with a 10b5-1 plan adopted by the Reporting Person on September 11, 2025 and maintained by the Reporting Person's financial advisor.
  • F6 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $615.26 to $629.96, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Einreichung öffnen 0001628280-26-005806 Aus dem XML der Einreichung gelesen Diese Zeile anfechten
4. Feb. 2026 Eingereicht am 6. Feb. 2026Moraco Anthony J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Erworben (A)256624,93
159.982,08

Abgeleitet: Aktien × Preis je Aktie. Exakter Wert 159982.08.

5.446Direkt (D) Nein
F1, F2, F3
  • F1 Shares were issued pursuant to the Company's 2024 Omnibus Incentive Plan in which non-employee directors receive an annual grant of restricted stock for service on the board. The restrictions on these shares lapse upon the shorter of (a) one year from the date of grant or (b) until such time as the service of the recipient as a non-employee Director of the Company shall have ended by reason of his or her (i) death or disability or (ii) failure to be reelected.
  • F2 The number of shares is arrived by dividing the closing price of the Issuer's securities on February 4, 2026 into $160,000, the amount of the stock award granted to the Issuer's non-employee directors. The number of shares is rounded down to the nearest whole share.
  • F3 Price is based on the close price for the Registrant's common stock on February 4, 2026, the date the reporting person earned the annual award.
Einreichung öffnen 0001628280-26-006021 Aus dem XML der Einreichung gelesen Diese Zeile anfechten

Institutionelle Halter (Formular 13F)

Quartal zum 2026-09-30: 8.793 Einreichungen gelesen, die jüngste vom 16. Nov. 2026. Vorquartal zum 2026-06-30: 9.164 Einreichungen gelesen.

1–50 von 875 angezeigt

Institutionelle Halter, größte Position zuerst, wie eingereicht
ManagerAktien oder NennbetragWert wie eingereichtDifferenz zum VorquartalQuelle
BlackRock, Inc. Teilweise unter einem anderen Manager gemeldet4.605.797 SH2.504.724.358 DollarHöher um 54.687 Vorquartal: 4.551.110Einreichung öffnen 0002012383-26-003985 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
STATE STREET CORP Teilweise unter einem anderen Manager gemeldet1.780.188 SH968.555.603 DollarHöher um 77.770 Vorquartal: 1.702.418Einreichung öffnen 0000093751-26-000747 Eingereicht am 12. Nov. 2026 Diese Zeile anfechten
VANGUARD CAPITAL MANAGEMENT LLC 1.656.167 SH900.656.738 DollarNiedriger um 12.845 Vorquartal: 1.669.012Einreichung öffnen 0002100119-26-001711 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
VANGUARD PORTFOLIO MANAGEMENT LLC 1.618.282 SH880.054.117 DollarNiedriger um 31.190 Vorquartal: 1.649.472Einreichung öffnen 0002100121-26-001150 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
Invesco Ltd. Teilweise unter einem anderen Manager gemeldet811.807 SH441.476.883 DollarNiedriger um 717.205 Vorquartal: 1.529.012Einreichung öffnen 0000914208-26-000462 Eingereicht am 12. Nov. 2026 Diese Zeile anfechten
GEODE CAPITAL MANAGEMENT, LLC Teilweise unter einem anderen Manager gemeldet691.661 SH375.057.520 DollarNiedriger um 49.998 Vorquartal: 741.659Einreichung öffnen 0001214717-26-000012 Eingereicht am 6. Nov. 2026 Diese Zeile anfechten
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ Teilweise unter einem anderen Manager gemeldet642.112 SH352.725.492 DollarNiedriger um 174.965 Vorquartal: 817.077Einreichung öffnen 0000912938-26-001073 Eingereicht am 12. Nov. 2026 Diese Zeile anfechten
VAN ECK ASSOCIATES CORP Teilweise unter einem anderen Manager gemeldet586.533 SH318.968.376 DollarHöher um 935 Vorquartal: 585.598Einreichung öffnen 0000869178-26-000119 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
PRIMECAP MANAGEMENT CO/CA/ 505.695 SH275.007.055 DollarNiedriger um 9.120 Vorquartal: 514.815Einreichung öffnen 0000763212-26-000037 Eingereicht am 12. Nov. 2026 Diese Zeile anfechten
MORGAN STANLEY Teilweise unter einem anderen Manager gemeldet504.275 SH274.236.801 DollarHöher um 83.406 Vorquartal: 420.869Einreichung öffnen 0000895421-26-000309 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
FRANKLIN TEMPLETON INC Teilweise unter einem anderen Manager gemeldet501.330 SH226.666.333 DollarNiedriger um 26.904 Vorquartal: 528.234Einreichung öffnen 0000038777-26-000291 Eingereicht am 12. Nov. 2026 Diese Zeile anfechten
FMR LLC Teilweise unter einem anderen Manager gemeldet461.207 SH250.814.224 DollarNiedriger um 5.869 Vorquartal: 467.076Einreichung öffnen 0000315066-26-002964 Eingereicht am 10. Nov. 2026 Diese Zeile anfechten
AQR CAPITAL MANAGEMENT LLC Teilweise unter einem anderen Manager gemeldet425.697 SH227.841.466 DollarNiedriger um 119.617 Vorquartal: 545.314Einreichung öffnen 0001167557-26-000324 Eingereicht am 16. Nov. 2026 Diese Zeile anfechten
Qube Research Technologies Ltd 396.079 SH215.395.682 DollarHöher um 368.355 Vorquartal: 27.724Einreichung öffnen 0001729829-26-000018 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
UBS Group AG Teilweise unter einem anderen Manager gemeldet362.151 SH196.944.957 DollarHöher um 153.691 Vorquartal: 208.460Einreichung öffnen 0001610520-26-000121 Eingereicht am 10. Nov. 2026 Diese Zeile anfechten
Bank of New York Mellon Corp Teilweise unter einem anderen Manager gemeldet345.722 SH188.010.424 DollarNiedriger um 11.196 Vorquartal: 356.918Einreichung öffnen 0001390777-26-000121 Eingereicht am 5. Nov. 2026 Diese Zeile anfechten
NORTHERN TRUST CORP Teilweise unter einem anderen Manager gemeldet344.293 SH187.233.419 DollarHöher um 13.976 Vorquartal: 330.317Einreichung öffnen 0000073124-26-000067 Eingereicht am 16. Nov. 2026 Diese Zeile anfechten
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 305.868 SH166.337.136 DollarNiedriger um 11.438 Vorquartal: 317.306Einreichung öffnen 0001644956-26-000031 Eingereicht am 6. Nov. 2026 Diese Zeile anfechten
Swedbank AB Teilweise unter einem anderen Manager gemeldet299.483 SH162.864.846 DollarHöher um 146.263 Vorquartal: 153.220Einreichung öffnen 0000946431-26-000009 Eingereicht am 27. Okt. 2026 Diese Zeile anfechten
GOLDMAN SACHS GROUP INC Teilweise unter einem anderen Manager gemeldet296.603 SH161.298.240 DollarHöher um 39.585 Vorquartal: 257.018Einreichung öffnen 0000886982-26-000647 Eingereicht am 16. Nov. 2026 Diese Zeile anfechten
MILLENNIUM MANAGEMENT LLC 279.602 SH152.053.160 DollarHöher um 247.146 Vorquartal: 32.456Einreichung öffnen 0001273087-26-000011 Eingereicht am 16. Nov. 2026 Diese Zeile anfechten
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Teilweise unter einem anderen Manager gemeldet264.736 SH143.968.731 DollarHöher um 87.713 Vorquartal: 177.023Einreichung öffnen 0000861177-26-000005 Eingereicht am 16. Nov. 2026 Diese Zeile anfechten
Allspring Global Investments Holdings, LLC Teilweise unter einem anderen Manager gemeldet253.383 SH138.078.531 DollarNiedriger um 5.510 Vorquartal: 258.893Einreichung öffnen 0001890906-26-000078 Eingereicht am 4. Nov. 2026 Diese Zeile anfechten
VANGUARD FIDUCIARY TRUST CO 236.715 SH128.730.351 DollarHöher um 482 Vorquartal: 236.233Einreichung öffnen 0000933478-26-000017 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Teilweise unter einem anderen Manager gemeldet236.531 SH128.630.288 DollarHöher um 52.898 Vorquartal: 183.633Einreichung öffnen 0001520354-26-000046 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 225.201 SH122.468.808 DollarNiedriger um 123.806 Vorquartal: 349.007Einreichung öffnen 0000884546-26-000417 Eingereicht am 16. Nov. 2026 Diese Zeile anfechten
DIMENSIONAL FUND ADVISORS LP Teilweise unter einem anderen Manager gemeldet220.464 SH119.873.914 DollarHöher um 8.943 Vorquartal: 211.521Einreichung öffnen 0000354204-26-001096 Eingereicht am 4. Nov. 2026 Diese Zeile anfechten
BLAIR WILLIAM CO/IL 220.416 SH119.866.418 DollarHöher um 34.807 Vorquartal: 185.609Einreichung öffnen 0001104659-26-124894 Eingereicht am 10. Nov. 2026 Diese Zeile anfechten
CITADEL ADVISORS LLC Teilweise unter einem anderen Manager gemeldet219.349 SH119.286.373 DollarHöher um 198.052 Vorquartal: 21.297Einreichung öffnen 0001104659-26-128228 Eingereicht am 16. Nov. 2026 Diese Zeile anfechten
FIRST TRUST ADVISORS LP 207.138 SH112.645.503 DollarHöher um 5.472 Vorquartal: 201.666Einreichung öffnen 0001445546-26-008622 Eingereicht am 12. Nov. 2026 Diese Zeile anfechten
AMERICAN CENTURY COMPANIES INC Teilweise unter einem anderen Manager gemeldet207.033 SH112.588.686 DollarNiedriger um 115.825 Vorquartal: 322.858Einreichung öffnen 0000748054-26-000008 Eingereicht am 12. Nov. 2026 Diese Zeile anfechten
Man Group plc Teilweise unter einem anderen Manager gemeldet206.688 SH112.401.069 DollarHöher um 191.352 Vorquartal: 15.336Einreichung öffnen 0001637460-26-000004 Eingereicht am 16. Nov. 2026 Diese Zeile anfechten
D. E. Shaw Co., Inc. Teilweise unter einem anderen Manager gemeldet202.082 SH109.896.233 DollarHöher um 190.318 Vorquartal: 11.764Einreichung öffnen 0001104659-26-128287 Eingereicht am 16. Nov. 2026 Diese Zeile anfechten
AXIOM INVESTORS LLC /DE 177.720 SH96.647.690 DollarHöher um 22.812 Vorquartal: 154.908Einreichung öffnen 0001109147-26-000007 Eingereicht am 12. Nov. 2026 Diese Zeile anfechten
BANK OF AMERICA CORP /DE/ Teilweise unter einem anderen Manager gemeldet177.715 SH96.644.856 DollarHöher um 13.971 Vorquartal: 163.744Einreichung öffnen 0000070858-26-000589 Eingereicht am 16. Nov. 2026 Diese Zeile anfechten
PRICE T ROWE ASSOCIATES INC /MD/ Teilweise unter einem anderen Manager gemeldet162.648 SH88.452 DollarNiedriger um 42.643 Vorquartal: 205.291Einreichung öffnen 0000080255-26-000736 Eingereicht am 16. Nov. 2026 Diese Zeile anfechten
Amundi Teilweise unter einem anderen Manager gemeldet159.441 SH86.707.204 DollarHöher um 4.773 Vorquartal: 154.668Einreichung öffnen 0001172661-26-004884 Eingereicht am 6. Nov. 2026 Diese Zeile anfechten
JPMORGAN CHASE CO Teilweise unter einem anderen Manager gemeldet155.993 SH84.381.966 DollarHöher um 2.405 Vorquartal: 153.588Einreichung öffnen 0000019617-26-000404 Eingereicht am 12. Nov. 2026 Diese Zeile anfechten
ALLIANCEBERNSTEIN L.P. Teilweise unter einem anderen Manager gemeldet155.622 SH84.630.027 DollarNiedriger um 54.072 Vorquartal: 209.694Einreichung öffnen 0001109448-26-000342 Eingereicht am 16. Nov. 2026 Diese Zeile anfechten
CONGRESS ASSET MANAGEMENT CO 155.176 SH84.387.939 DollarNiedriger um 43.582 Vorquartal: 198.758Einreichung öffnen 0000897378-26-000015 Eingereicht am 6. Okt. 2026 Diese Zeile anfechten
VICTORY CAPITAL MANAGEMENT INC 153.483 SH83.467.043 DollarNiedriger um 1.301 Vorquartal: 154.784Einreichung öffnen 0001040188-26-000051 Eingereicht am 10. Nov. 2026 Diese Zeile anfechten
TimesSquare Capital Management, LLC 152.917 SH83.159.323 DollarNiedriger um 11.611 Vorquartal: 164.528Einreichung öffnen 0001193125-26-444305 Eingereicht am 3. Nov. 2026 Diese Zeile anfechten
Cardano Risk Management B.V. 147.218 SH80.060 DollarHöher um 4.282 Vorquartal: 142.936Einreichung öffnen 0001619124-26-000009 Eingereicht am 20. Okt. 2026 Diese Zeile anfechten
Sumitomo Mitsui Trust Group, Inc. Teilweise unter einem anderen Manager gemeldet138.030 SH75.063.475 DollarNiedriger um 64.232 Vorquartal: 202.262Einreichung öffnen 0001214659-26-013361 Eingereicht am 29. Okt. 2026 Diese Zeile anfechten
SCHRODER INVESTMENT MANAGEMENT GROUP Teilweise unter einem anderen Manager gemeldet131.680 SH70.297.368 DollarHöher um 4.922 Vorquartal: 126.758Einreichung öffnen 0001140361-26-044129 Eingereicht am 16. Nov. 2026 Diese Zeile anfechten
Quantinno Capital Management LP 130.540 SH70.990.312 DollarNiedriger um 52.447 Vorquartal: 182.987Einreichung öffnen 0001759654-26-000011 Eingereicht am 13. Nov. 2026 Diese Zeile anfechten
BARCLAYS PLC Teilweise unter einem anderen Manager gemeldet130.088 SH70.744.457 DollarHöher um 81.847 Vorquartal: 48.241Einreichung öffnen 0000312069-26-000241 Eingereicht am 6. Nov. 2026 Diese Zeile anfechten
WEDGE CAPITAL MANAGEMENT L L P/NC 128.328 SH69.787.333 DollarHöher um 22.720 Vorquartal: 105.608Einreichung öffnen 0001015308-26-000008 Eingereicht am 13. Okt. 2026 Diese Zeile anfechten
Fisher Asset Management, LLC Teilweise unter einem anderen Manager gemeldet127.159 SH69.151.843 DollarHöher um 8.229 Vorquartal: 118.930Einreichung öffnen 0000850529-26-000009 Eingereicht am 6. Nov. 2026 Diese Zeile anfechten
DEUTSCHE BANK AG\ Teilweise unter einem anderen Manager gemeldet126.193 SH68.626.277 DollarNiedriger um 7.769 Vorquartal: 133.962Einreichung öffnen 0000948046-26-000083 Eingereicht am 6. Nov. 2026 Diese Zeile anfechten
Manager des Vorquartals ohne gelesene Einreichung für das neueste

Sie haben möglicherweise nur noch nicht eingereicht: Das Fehlen in den gelesenen Einreichungen des neuesten Quartals bedeutet nicht, dass die Position verkauft wurde.

  • NORGES BANK 506.330 SH
  • Sixth Street Partners Management Company, L.P. 349.007 SH
  • Driehaus Capital Management LLC 229.123 SH
  • Zurich Insurance Group Ltd/FI 104.480 SH
  • Wealth High Governance Asset Management Ltda. 43.434 SH
  • HWG Holdings LP 43.104 SH
  • NEW YORK STATE COMMON RETIREMENT FUND 42.801 SH
  • SCOPUS ASSET MANAGEMENT, L.P. 40.000 SH
  • SCOPUS ASSET MANAGEMENT, L.P. 35.000 SH
  • SCOPUS ASSET MANAGEMENT, L.P. 33.642 SH
  • AGF MANAGEMENT LTD 26.731 SH
  • Hood River Capital Management LLC 23.239 SH
  • Dorsey Wright Associates 17.562 SH
  • Tredje AP-fonden 16.855 SH
  • BW Gestao de Investimentos Ltda. 16.571 SH
  • Wealth High Governance Capital Ltda 16.566 SH
  • Waratah Capital Advisors Ltd. 14.316 SH
  • SG Americas Securities, LLC 11.504 SH
  • Jain Global LLC 11.151 SH
  • Public Sector Pension Investment Board 9.000 SH
  • CAPSTONE INVESTMENT ADVISORS, LLC 8.259 SH
  • Pacer Advisors, Inc. 8.096 SH
  • ABN AMRO Bank N.V. 7.157 SH
  • ALGERT GLOBAL LLC 6.993 SH
  • Summit Trail Advisors, LLC 5.153 SH
  • Bellwether Advisors, LLC 4.553 SH
  • PEAK FINANCIAL ADVISORS LLC 4.503 SH
  • ALLSTATE CORP 4.442 SH
  • Caprock Group, LLC 4.224 SH
  • Integrated Wealth Concepts LLC 3.810 SH
  • Jupiter Topco LLC 3.806 SH
  • GLOBEFLEX CAPITAL L P 3.650 SH
  • PINNBROOK CAPITAL MANAGEMENT LP 3.280 SH
  • Genus Capital Management Inc. 3.200 SH
  • MARSHALL WACE, LLP 3.160 SH
  • United Super Pty Ltd in its capacity as Trustee for the Construction Building Unions Superannuation Fund 3.080 SH
  • DDFG, Inc 2.860 SH
  • MILLENNIUM MANAGEMENT LLC 2.800 SH
  • Lisanti Capital Growth, LLC 2.450 SH
  • Coastal Bridge Advisors, LLC 2.261 SH
  • GeoWealth Management, LLC 1.985 SH
  • Brookwood Investment Group LLC 1.950 SH
  • Jupiter Research Capital (Asia) Ltd 1.935 SH
  • Bannerstone Capital Management, LLC 1.861 SH
  • VestGen Investment Management 1.781 SH
  • QP WEALTH MANAGEMENT, LLC 1.661 SH
  • Corient IA LP 1.620 SH
  • Sigma Planning Corp 1.567 SH
  • Proficio Capital Partners LLC 1.246 SH
  • AdvisorShares Investments LLC 1.040 SH
  • Das Formular 13F umfasst nur Long-Positionen in Wertpapieren nach Section 13(f): keine Short-Positionen und keine Wertpapiere außerhalb dieser Liste.
  • Ein Manager, der für das neueste Quartal noch nicht eingereicht hat, fehlt und steht nicht bei null; die Frist beträgt bis zu 45 Tage nach Quartalsende.
  • Eine Differenz ist der Unterschied zwischen zwei Quartalsstichtagen, keine Transaktion.
  • Eine unter einem anderen Manager gemeldete Position kann auch in dessen Einreichung erscheinen; die Zeilen werden nicht addiert.
  • Positionen, die die Wertpapierliste diesem Unternehmen nicht oder nur mehrdeutig zuordnen kann, werden nicht angezeigt.

5-%-Halter (Schedule 13D und 13G)

Hier werden im strukturierten SEC-Format (ab Ende 2024) eingereichte Schedules gelesen. Frühere sind Freitext und werden nicht gelesen.

5-%-Halter, jüngstes Ereignis zuerst, wie eingereicht
HalterProzent der GattungGehaltene AktienEreignisdatumFormularQuelle
Vanguard Capital Management Common Stock5.211.923.45303/31/2026 Eingereicht am 29. Apr. 2026SCHEDULE 13GEinreichung öffnen 0002100119-26-000443 Diese Zeile anfechten
The Vanguard Group Common Stock0003/13/2026 Eingereicht am 26. März 2026SCHEDULE 13G/AÄnderung 12Einreichung öffnen 0000102909-26-001101 Diese Zeile anfechten

Der Prozentsatz bezieht sich auf die in der Einreichung genannte Gattung, wie vom Halter angegeben. Gruppenmitglieder melden jeweils die Aktien der Gruppe; die Zeilen werden daher nicht addiert.

Was gelesen wurde

2.241.199 Einreichungen gelesen, vom 14. Juni 2004 bis 16. Nov. 2026: Formulare 3, 3/A, 4, 4/A, 5, 5/A.

Jahre können unvollständig sein, solange das Archiv noch gelesen wird. Ein Jahr mit wenigen Einreichungen hier besagt nicht, dass wenige gemacht wurden.

Gelesene Einreichungen nach Einreichungsjahr
EinreichungsjahrGelesene Einreichungen
20151
2016204.322
2017202.494
2018202.048
2019193.638
2020144.184
2021224.474
2022158.941
2023199.811
2024209.823
2025235.520
2026260.165

Einreichungen aus der Zeit vor der XML-Pflicht der SEC sind aufgeführt, aber nicht ausgelesen.

Zurück zu CURTISS-WRIGHT CORPORATION